放射性125I粒子植入治疗恶性实体肿瘤技术质量管理核医学专家共识(2019年版)

2020-11-30 中华医学会核医学分会 中华核医学与分子影像杂志.2020.40(11):673-678.

放射性125I 粒子植入治疗技术已被广泛应用各种恶性肿瘤的综合治疗中。近年来核医学开展的放射性125I 粒子植入治疗量逐年增加,成为核素治疗的重要项目。为了推进及规范核医学放射性125I 粒子植入治疗

中文标题:

放射性125I粒子植入治疗恶性实体肿瘤技术质量管理核医学专家共识(2019年版)

发布日期:

2020-11-30

简要介绍:

放射性125I 粒子植入治疗技术已被广泛应用各种恶性肿瘤的综合治疗中。近年来核医学开展的放射性125I 粒子植入治疗量逐年增加,成为核素治疗的重要项目。为了推进及规范核医学放射性125I 粒子植入治疗工作、加强质量控制、开展大数据研究及多学科合作以及规范临床治疗,中华医学会核医学分会治疗学组组织了治疗学组放射性粒子介入治疗工作委员会部分专家,借鉴目前国内外指南及最新研究,参考相关法律法规,结合我国临床现状,起草制定本共识。本共识包括一般要求、质量管理控制、防护要求3 个部分。放射性125 I 粒子植入治疗作为放射性介入治疗,具有核素介入临床技术及放射性核素管理二重特点,本共识通过在技术质量控制和放射性核素管理2 个方面进行规范,从根本上逐步解决粒子植入治疗领域的问题,以提高治疗效果,促进放射性125 I 粒子植入治疗工作的顺利开展。

下载附件:

(因为版权问题,不支持下载)

评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1206281, encodeId=00311206281f1, content=值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b106486700, createdName=ms1000000655164981, createdTime=Sun Mar 27 09:11:50 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009509, encodeId=975d1009509f0, content=强!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Thu Aug 19 17:05:59 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000300, encodeId=28f91000300a5, content=好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210717/2a4a9b6d7d74400786253d5eba837e09/33a98bde60dd4b79ab2d86ab71c46c8a.jpg, createdBy=23652467800, createdName=1242f175m11暂无昵称, createdTime=Sat Jul 17 08:46:49 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911395, encodeId=d47991139557, content=终于有共识了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Dec 27 21:05:00 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919142, encodeId=5240919142c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSUwPO4K0jkCrTG5BbuxWm6icmp6fO9GfEoFu4n87hpPXxPQdR8V7PQD4nJVjBWOFofoVS6Yajkeg/132, createdBy=804e5331184, createdName=徽徽, createdTime=Sat Jan 23 02:47:23 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2022-03-27 ms1000000655164981

    值得学习。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1206281, encodeId=00311206281f1, content=值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b106486700, createdName=ms1000000655164981, createdTime=Sun Mar 27 09:11:50 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009509, encodeId=975d1009509f0, content=强!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Thu Aug 19 17:05:59 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000300, encodeId=28f91000300a5, content=好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210717/2a4a9b6d7d74400786253d5eba837e09/33a98bde60dd4b79ab2d86ab71c46c8a.jpg, createdBy=23652467800, createdName=1242f175m11暂无昵称, createdTime=Sat Jul 17 08:46:49 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911395, encodeId=d47991139557, content=终于有共识了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Dec 27 21:05:00 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919142, encodeId=5240919142c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSUwPO4K0jkCrTG5BbuxWm6icmp6fO9GfEoFu4n87hpPXxPQdR8V7PQD4nJVjBWOFofoVS6Yajkeg/132, createdBy=804e5331184, createdName=徽徽, createdTime=Sat Jan 23 02:47:23 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-08-19 黄威龙

    强!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1206281, encodeId=00311206281f1, content=值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b106486700, createdName=ms1000000655164981, createdTime=Sun Mar 27 09:11:50 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009509, encodeId=975d1009509f0, content=强!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Thu Aug 19 17:05:59 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000300, encodeId=28f91000300a5, content=好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210717/2a4a9b6d7d74400786253d5eba837e09/33a98bde60dd4b79ab2d86ab71c46c8a.jpg, createdBy=23652467800, createdName=1242f175m11暂无昵称, createdTime=Sat Jul 17 08:46:49 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911395, encodeId=d47991139557, content=终于有共识了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Dec 27 21:05:00 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919142, encodeId=5240919142c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSUwPO4K0jkCrTG5BbuxWm6icmp6fO9GfEoFu4n87hpPXxPQdR8V7PQD4nJVjBWOFofoVS6Yajkeg/132, createdBy=804e5331184, createdName=徽徽, createdTime=Sat Jan 23 02:47:23 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-07-17 1242f175m11暂无昵称

    好!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1206281, encodeId=00311206281f1, content=值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b106486700, createdName=ms1000000655164981, createdTime=Sun Mar 27 09:11:50 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009509, encodeId=975d1009509f0, content=强!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Thu Aug 19 17:05:59 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000300, encodeId=28f91000300a5, content=好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210717/2a4a9b6d7d74400786253d5eba837e09/33a98bde60dd4b79ab2d86ab71c46c8a.jpg, createdBy=23652467800, createdName=1242f175m11暂无昵称, createdTime=Sat Jul 17 08:46:49 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911395, encodeId=d47991139557, content=终于有共识了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Dec 27 21:05:00 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919142, encodeId=5240919142c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSUwPO4K0jkCrTG5BbuxWm6icmp6fO9GfEoFu4n87hpPXxPQdR8V7PQD4nJVjBWOFofoVS6Yajkeg/132, createdBy=804e5331184, createdName=徽徽, createdTime=Sat Jan 23 02:47:23 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2020-12-27 oo902

    终于有共识了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1206281, encodeId=00311206281f1, content=值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b106486700, createdName=ms1000000655164981, createdTime=Sun Mar 27 09:11:50 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009509, encodeId=975d1009509f0, content=强!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Thu Aug 19 17:05:59 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000300, encodeId=28f91000300a5, content=好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210717/2a4a9b6d7d74400786253d5eba837e09/33a98bde60dd4b79ab2d86ab71c46c8a.jpg, createdBy=23652467800, createdName=1242f175m11暂无昵称, createdTime=Sat Jul 17 08:46:49 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911395, encodeId=d47991139557, content=终于有共识了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Dec 27 21:05:00 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919142, encodeId=5240919142c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSUwPO4K0jkCrTG5BbuxWm6icmp6fO9GfEoFu4n87hpPXxPQdR8V7PQD4nJVjBWOFofoVS6Yajkeg/132, createdBy=804e5331184, createdName=徽徽, createdTime=Sat Jan 23 02:47:23 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-01-23 徽徽

    学习学习

    0